ID

29055

Description

Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage

Keywords

  1. 10/5/17 10/5/17 -
  2. 2/22/18 2/22/18 -
  3. 2/22/18 2/22/18 -
  4. 2/22/18 2/22/18 -
  5. 9/17/21 9/17/21 -
Copyright Holder

gsk

Uploaded on

February 22, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Ropinirole Case Report Form GSK RRL100013

INVESTIGATIONAL PRODUCT

Investigational Product
Description

Investigational Product

Alias
UMLS CUI-1
C0304229
Planned timepoint
Description

Planned timepoint

Data type

integer

Alias
UMLS CUI [1]
C2348792
Blinded dose level
Description

Blinded dose level

Data type

integer

Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C0304229
Start Date
Description

Start Date

Data type

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0304229
Stop Date
Description

Stop Date

Data type

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C0304229
IP Container No. 1
Description

IP Container No 1

Data type

text

Alias
UMLS CUI [1,1]
C0180098
UMLS CUI [1,2]
C0304229
IP Container No. 2
Description

IP Container No 2

Data type

text

Alias
UMLS CUI [1,1]
C0180098
UMLS CUI [1,2]
C0304229
Has the subject missed investigational product for >2 consecutive days
Description

Has the subject missed investigational product for >2 consecutive days

Data type

boolean

Alias
UMLS CUI [1]
C0457454
Average number of hours between early and late dose
Description

Average number of hours between early and late dose

Data type

text

Similar models

INVESTIGATIONAL PRODUCT

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Investigational Product
C0304229 (UMLS CUI-1)
Item
Planned timepoint
integer
C2348792 (UMLS CUI [1])
Code List
Planned timepoint
CL Item
Baseline (1)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
Day 3 (2)
(Comment:en)
CL Item
Vital signs (3)
C0518766 (UMLS CUI-1)
(Comment:en)
Blinded dose level
Item
Blinded dose level
integer
C0178602 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
IP Container No 1
Item
IP Container No. 1
text
C0180098 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
IP Container No 2
Item
IP Container No. 2
text
C0180098 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Has the subject missed investigational product for >2 consecutive days
Item
Has the subject missed investigational product for >2 consecutive days
boolean
C0457454 (UMLS CUI [1])
Average number of hours between early and late dose
Item
Average number of hours between early and late dose
text

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial